A newly developed light-sensing protein called the MCO1 opsin restores vision in blind mice when attached to retina bipolar cells using gene therapy. The National Eye Institute, part of the National Institutes of Health, ...
Oct 22, 2020
0
167
Zellweger syndrome is a rare disease which at its mildest form can cause developmental delays in childhood and vision and hearing loss in adulthood. At its most severe, it can mean weak muscle tone, feeding and respiratory ...
Sep 30, 2020
0
1
Retinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, LMU researchers have now shown that targeted activation of genes of similar function can compensate for the ...
Sep 02, 2020
0
8
A series of papers published recently by two teams of vision researchers at the University at Buffalo and the University of Alabama at Birmingham (UAB) is revealing important new information about the possible cause of a ...
Jun 24, 2020
0
6
Researchers who made a knock-in mouse-model of the genetic disorder retinitis pigmentosa 59, or RP59, expected to see retinal degeneration and retinal thinning. As reported in the journal Cells, they surprisingly found none, ...
Jun 11, 2020
0
25
Mice born blind have shown significant improvement in vision after undergoing a new gene therapy developed by a team of Japanese scientists.
Feb 07, 2020
0
16
A genetic mutation that leads to a rare, but devastating blindness-causing syndrome has been discovered in monkeys for the first time. The finding offers a promising way to develop gene and cell therapies that could treat ...
Oct 25, 2019
0
158
Blind and partially sighted people no longer have to wait passively for a research breakthrough in hope of treatment options. In fact, people living with genetic eye conditions can now actively drive vision research forward ...
Oct 17, 2019
0
11
Nearly one in 30 Americans over the age of 40 experience low vision—significant visual impairment that can't be corrected with glasses, contact lenses, medication or surgery.
Aug 26, 2019
0
129
Scientists from EPFL in Switzerland and Scuola Superiore Sant"Anna in Italy are developing technology for the blind that bypasses the eyeball entirely and sends messages to the brain. They do this by stimulating the optic ...
Aug 15, 2019
0
158
Retinitis pigmentosa (RP) is a group of genetic eye conditions that leads to incurable blindness. In the progression of symptoms for RP, night blindness generally precedes tunnel vision by years or even decades. Many people with RP do not become legally blind until their 40s or 50s and retain some sight all their lives. Others go completely blind from RP, in some cases as early as childhood. Progression of RP is different in each case.
RP is a type of progressive retinal dystrophy, a group of inherited disorders in which abnormalities of the photoreceptors (rods and cones) or the retinal pigment epithelium (RPE) of the retina lead to progressive visual loss. Affected individuals first experience defective dark adaptation or nyctalopia (night blindness), followed by reduction of the peripheral visual field (known as tunnel vision) and, sometimes, loss of central vision late in the course of the disease.
This text uses material from Wikipedia licensed under CC BY-SA
